Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Standard osteoporosis interventions (bisphosphonates, denosumab, teriparatide) target osteoclast inhibition or systemic bone turnover
Avoid phosphate buffers if preparing custom formulations
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P.E., Zhou, X., Li, C., Shen, G., Zou, Bingwen, NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential, Signal Transduction and Targeted Therapy
Because the treatments (V, CS, C, S, WM, PF) were not distributed evenly among the experiments, experiment was not used as a covariate in the pooled analysis
US$ 26.70
US$ 20.95
US$ 21.27
US$ 26.97
